Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?

"Declarations Conflict of InterestU.M.P. reports consulting agreements from Merck, outside the submitted work. C.A.K has received grant support to the University of California, San Francisco from the Gilead Research Scholars Program in HIV. J.W.M. reports consulting agreements from Gilead Sciences, Inc., and Infectious Disease Connect, and shares/share options from Infectious Disease Connect and Abound Bio, outside the submitted work. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflict of Interest U.M.P. reports consulting agreements from Merck, outside the submitted work. C.A.K has received grant support to the University of California, San Francisco from the Gilead Research Scholars Program in HIV. J.W.M. reports consulting agreements from Gilead Sciences, Inc., and Infectious Disease Connect, and shares/share options from Infectious Disease Connect and Abound Bio, outside the submitted work."

"Funding This review is made possible by the generous support of the American people through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID) cooperative agreement 7200AA21CA00011. The contents are the responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID or the United States Government. Research reported in this publication was supported by a grant from the AIDS Clinical Trials Group Network (ACTG) to the University of Pittsburgh Virology Specialty Laboratory funded by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) under Award Number UM1 AI106701, and, by a grant to the HIV Prevention Trials Network (HPTN) under Award Number UM1 AI068619 (Parikh and Mellors). This work was also supported by NIAID under award number R01AI167753 (Koss, Parikh) and the National Institute of Mental Health (NIMH) under award number K23 MH114760 (Koss). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health, or the National Institutes of Health."